Geographic differences in outcomes in outpatients with established atherothrombotic disease: Results from the REACH Registry

European Journal of Preventive Cardiology

Volumn 21, Issue 12, 2014, Pages 1509-1516

  Ducrocq, G ^a,j   Bhatt, D L ^b   Labreuche, J ^a,j   Corbalan, R ^c   Porath, A ^d   Gao, R ^e   Panchenko, E ^f   Liau, C S ^g   Ikeda, Y ^h   Goto, S ⁱ   Amarenco, P ^a,j   Steg, P G ^a,j  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HARVARD MEDICAL SCHOOL   (United States)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^d BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^e FUWAI HOSPITAL   (China)

^f Russian Federation   (Russian Federation)

^g NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^h KOKURA MEMORIAL HOSPITAL   (Japan)

ⁱ TOKAI UNIVERSITY   (Japan)

^j BICHAT HOSPITAL   (France)

more..

Author keywords

atherothrombotic disease; bleeding; Geographic differences; ischemic outcomes

Indexed keywords

AGED; ARTICLE; ASIA; BLEEDING; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CORONARY ARTERY DISEASE; DEMOGRAPHY; DISEASE REGISTRY; EASTERN EUROPE; FEMALE; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; HEART INFARCTION; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MIDDLE EAST; NORTH AMERICA; OUTCOME ASSESSMENT; OUTPATIENT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RISK ASSESSMENT; SOUTH AND CENTRAL AMERICA; WESTERN EUROPE; ATHEROSCLEROSIS; CEREBROVASCULAR DISORDERS; CLINICAL PRACTICE; CLINICAL TRIAL; COMPARATIVE STUDY; HEALTH CARE DISPARITY; HEALTH DISPARITY; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PERIPHERAL ARTERIAL DISEASE; PREVALENCE; REGISTER; THROMBOSIS; TIME; TREATMENT OUTCOME; TRENDS;

AGED; ATHEROSCLEROSIS; CEREBROVASCULAR DISORDERS; CORONARY ARTERY DISEASE; FEMALE; HEALTH STATUS DISPARITIES; HEALTHCARE DISPARITIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; OUTPATIENTS; PERIPHERAL ARTERIAL DISEASE; PHYSICIAN'S PRACTICE PATTERNS; PREVALENCE; REGISTRIES; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84911917280     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/2047487313501278     Document Type: Article

References (27)

1. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012 ; 380: 2095-2128
2. Roe MT, Armstrong PW, Fox KA, et al. Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. N Engl J Med. 2012 ; 367: 1297-1309
3. Schwartz GG, Olsson AG, Abt M, et al. Effects of dalcetrapib in patients with a recent acute coronary syndrome. N Engl J Med. 2012 ; 367: 2089-2099
4. Bhatt DL, Steg PG, Ohman EM, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA. 2006 ; 295: 180-189
5. Ohman EM, Bhatt DL, Steg PG, et al. The REduction of Atherothrombosis for Continued Health (REACH) Registry: An international, prospective, observational investigation in subjects at risk for atherothrombotic events-study design. Am Heart J. 2006 ; 151: 786 e1-10
6. Steg PG, Bhatt DL, Wilson PW, et al. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA. 2007 ; 297: 1197-1206
7. Bhatt DL, Eagle KA, Ohman EM, et al. Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis. JAMA. 2010 ; 304: 1350-1357
8. Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004 ; 363: 157-163
9. Dallongeville J, Bhatt DL, Steg PH, et al. Relation between body mass index, waist circumference, and cardiovascular outcomes in 19,579 diabetic patients with established vascular disease: The REACH Registry. Eur J Prev Cardiol. 2012 ; 19: 241-249
10. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009 ; 120: 1640-1645
11. Wilson PW, D'Agostino R, Bhatt DL, et al. An international model to predict recurrent cardiovascular disease. Am J Med. 2012 ; 125: 695-703 e1
12. Ducrocq G, Wallace JS, Baron G, et al. Risk score to predict serious bleeding in stable outpatients with or at risk of atherothrombosis. Eur Heart J. 2010 ; 31: 1257-1265
13. Ghali WA, Quan H, Brant R, et al. Comparison of 2 methods for calculating adjusted survival curves from proportional hazards models. JAMA. 2001 ; 286: 1494-1497
14. Yusuf S, Reddy S, Ounpuu S, et al. Global burden of cardiovascular diseases: Part II: Variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation. 2001 ; 104: 2855-2864
15. Bhatt DL, Roe MT, Peterson ED, et al. Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: Results from the CRUSADE Quality Improvement Initiative. JAMA. 2004 ; 292: 2096-2104
16. Steg PG, Goldberg RJ, Gore JM, et al. Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). Am J Cardiol. 2002 ; 90: 358-363
17. Fox KA, Cokkinos DV, Deckers J, et al. The ENACT study: A pan-European survey of acute coronary syndromes. European Network for Acute Coronary Treatment. Eur Heart J. 2000 ; 21: 1440-1449
18. Daly CA, Stepinska J, Deptuch T, et al. Differences in presentation and management of stable angina from East to West in Europe: A comparison between Poland and the UK. Int J Cardiol. 2008 ; 125: 311-318
19. Mandelzweig L, Battler A, Boyko V, et al. The second Euro Heart Survey on acute coronary syndromes: Characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004. Eur Heart J. 2006 ; 27: 2285-2293
20. Lenzen MJ, Boersma E, Bertrand ME, et al. Management and outcome of patients with established coronary artery disease: The Euro Heart Survey on coronary revascularization. Eur Heart J. 2005 ; 26: 1169-1179
21. Venkitachalam L, Wang K, Porath A, et al. Global variation in the prevalence of elevated cholesterol in outpatients with established vascular disease or 3 cardiovascular risk factors according to national indices of economic development and health system performance. Circulation. 2012 ; 125: 1858-1869
22. Worth RM, Kato H, Rhoads GG, et al. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: Mortality. Am J Epidemiol. 1975 ; 102: 481-490
23. Goyal A, Bhatt DL, Steg PG, et al. Attained educational level and incident atherothrombotic events in low- and middle-income compared with high-income countries. Circulation. 2010 ; 122: 1167-1175
24. Yusuf S, Islam S, Chow CK, et al. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): A prospective epidemiological survey. Lancet. 2011 ; 378: 1231-1243
25. Bueno H, Armstrong PW, Buxton MJ, et al. The future of clinical trials in secondary prevention after acute coronary syndromes. Eur Heart J. 2011 ; 32: 1583-1589
26. Glickman SW, McHutchison JG, Peterson ED, et al. Ethical and scientific implications of the globalization of clinical research. N Engl J Med. 2009 ; 360: 816-823
27. Rothwell PM, Coull AJ, Silver LE, et al. Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet. 2005 ; 366: 1773-1783